Reply Signs Strategic Collaboration Agreement with AWS to Accelerate AI-Driven Cloud Transformation April 2, 2026 Reply [EXM, STAR: REY] announced today that it has signed a strategic collaboration agreement (SCA) with Amazon Web Services (AWS) to accelerate the adoption of cloud and artificial intelligence solutions across key international markets. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260402597802/en/ At the core of the SCA is a strong focus [...]
Scottish AI and Software Development Firm Zudu Appoints New CEO and Moves Edinburgh HQ April 2, 2026 - New CEO Paul Duffy says big question for business leaders is do their companies have the delivery capability to close the AI gap - Zudu forecasting £5m revenue in current year and £10m by 2028
OLX Launches AutoGPT: Agentic AI Assistant Transforming Automotive Search Across Europe April 2, 2026 AutoGPT uses conversational AI to let car buyers describe their needs in plain language Currently live in Poland and soon to be launched in France, Romania, and Portugal marking the next phase in intuitive automotive search Developed as part of OLX's $200M+ investment in AI innovation across its marketplace platforms
SecurityTech on the Rise: G+D Reports Strong Order Intake and High Resilience in 2025 April 2, 2026 In fiscal year 2025, Giesecke+Devrient (G+D) reaffirmed its position as global leader in SecurityTech for mission-critical infrastructure. In a market where security is becoming essential for technological and societal stability, G+D demonstrates strong growth prospects. In 2025, G+D achieved a record order intake of €3.6 billion (+8%). Revenue increased to €3.2 billion (+1%), although exchange [...]
Samsung Biologics Under CEO John Rim Faces New ESG Risk After Rejecting Ruling in Contract Worker Discrimination Case April 2, 2026 After the Incheon Regional Labor Relations Commission ruled in Case No. Incheon 2025 Discrimination 10 that the exclusion of contract workers from holiday gift benefits constituted discriminatory treatment, the company sought review before the National Labor Relations Commission The dispute involved only about $10,000 in total, raising broader concerns over discrimination, human rights, and ESG credibility
Bureau Veritas Launches an Independent AI Assessment Offering for European Enterprises, Developed in Partnership with Amazon Web Services (AWS) April 1, 2026 Bureau Veritas, a global leader in Testing, Inspection, and Certification services (TIC), announces the launch of an AI systems audit to help European enterprises assess and demonstrate their compliance with the European Union’s “AI Act” regulatory requirements. This offering combines on-site audits, document analysis, and direct testing to deliver an independent maturity report. Since the [...]
KBRA Comments on FCA Finalising Motor Finance Compensation Scheme; No Change to UK Auto ABS Outlook April 1, 2026 The Financial Conduct Authority (FCA) has finalised its compensation scheme for discretionary commission arrangements in UK motor finance, providing greater clarity on the potential scale of redress. In its August 2025 commentary on the implications of motor finance litigation for UK auto ABS, KBRA highlighted the FCA’s earlier estimate of total sector costs ranging from [...]
OneTeam Partners and EnTrust Global Launch EnOne Ventures April 1, 2026 New early- to growth-stage venture creates institutional investment platform to target sports-adjacent businesses
Microland Announces Appointment of Sam Mathew as Chief Executive Officer April 1, 2026 Microland, a leading AI-first, platform-led technology infrastructure services company, today announced the appointment of Sam Mathew as Chief Executive Officer. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260401906896/en/ Sam Mathew has been serving as President of Microland, where he has led key global markets and strategic initiatives over the past 18 months. [...]
Alkermes Announces Initiation of Phase 3 Brilliance Studies Evaluating Alixorexton for the Treatment of Narcolepsy Type 1 and Type 2 April 1, 2026 Alkermes plc (Nasdaq: ALKS) today announced the initiation of the Brilliance Studies, a phase 3 program evaluating the safety and efficacy of alixorexton compared to placebo in adults with narcolepsy type 1 (NT1) and narcolepsy type 2 (NT2). Alixorexton is the company’s novel, investigational, oral, selective orexin 2 receptor (OX2R) agonist in development for the [...]
